Cargando…
Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
BACKGROUND: Depression is one of the leading causes of disability worldwide. A high proportion of patients do not respond to standard drug treatments. Recent evidence has suggested that anti-inflammatory treatment may have beneficial effects in major depression. Minocycline is a tetracycline antibio...
Autores principales: | Husain, Muhammad I., Chaudhry, Imran B., Rahman, Raza R., Hamirani, Munir M., Qurashi, Inti, Khoso, Ameer B., Deakin, John FW, Husain, Nusrat, Young, Allan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570147/ https://www.ncbi.nlm.nih.gov/pubmed/26374703 http://dx.doi.org/10.1186/s13063-015-0933-5 |
Ejemplares similares
-
Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial
por: Husain, Muhammad I, et al.
Publicado: (2016) -
Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial
por: Husain, Muhammad I., et al.
Publicado: (2019) -
A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol
por: Qurashi, Inti, et al.
Publicado: (2017) -
Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study
por: Qurashi, Inti, et al.
Publicado: (2016) -
A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial
por: Chaudhry, Imran B, et al.
Publicado: (2015)